Literature DB >> 24126512

The diabetic foot: a review.

J B Ricco1, L Thanh Phong, F Schneider, G Illuminati, R Belmonte, A Valagier, G Régnault De La Mothe.   

Abstract

Diabetic foot ulceration (DFU) is among the most frequent complications of diabetes. Neuropathy and ischaemia are the initiating factors and infection is mostly a consequence. We have shown in this review that any DFU should be considered to have vascular impairment. DFU will generally heal if the toe pressure is >55 mmHg and a transcutaneous oxygen pressure (TcPO2) <30 mmHg has been considered to predict that a diabetic ulcer may not heal. The decision to intervene is complex and made according to the symptoms and clinical findings. If both an endovascular and a bypass procedure are possible with an equal outcome to be expected, endovascular treatments should be preferred. Primary and secondary mid-term patency rates are better after bypass, but there is no difference in limb salvage. Bedridden patients with poor life expectancy and a non-revascularisable leg are indications for performing a major amputation. A deep infection is the immediate cause of amputation in 25% to 50% of diabetic patients. Patients with uncontrolled abscess, bone or joint involvement, gangrene, or necrotising fasciitis have a "foot-at risk" and need prompt surgical intervention with debridement and revascularisation. As demonstrated in this review, foot ulcer in diabetic is associated with high mortality and morbidity. Early referral, non-invasive vascular testing, imaging and intervention are crucial to improve DFU healing and to prevent amputation. Diabetics are eight to twenty-four times more likely than non-diabetics to have a lower limb amputation and it has been suggested that a large part of those amputations could be avoided by an early diagnosis and a multidisciplinary approach.

Entities:  

Mesh:

Year:  2013        PMID: 24126512

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  14 in total

1.  The use of an occlusion perfusion catheter to deliver paclitaxel to the arterial wall.

Authors:  Marzieh K Atigh; Emily Turner; Uwe Christians; Saami K Yazdani
Journal:  Cardiovasc Ther       Date:  2017-08       Impact factor: 3.023

2.  Next science wound gel technology, a novel agent that inhibits biofilm development by gram-positive and gram-negative wound pathogens.

Authors:  Kyle G Miller; Phat L Tran; Cecily L Haley; Cassandra Kruzek; Jane A Colmer-Hamood; Matt Myntti; Abdul N Hamood
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

3.  Implantation of placenta-derived mesenchymal stem cells accelerates murine dermal wound closure through immunomodulation.

Authors:  Haifeng Wang; Lianyu Chen; Yang Liu; Bangzhen Luo; Nanzi Xie; Tao Tan; Lige Song; Pei Erli; Ming Luo
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

4.  Fondaparinux for intra and perioperative anticoagulation in patients with heparin-induced thrombocytopenia candidates for peripheral vascular surgery: Report of 4 cases.

Authors:  Giulio Illuminati; Francesco G Calio'; Giulia Pizzardi; Chiara Amatucci; Federica Masci; Piergaspare Palumbo
Journal:  Int J Surg Case Rep       Date:  2016-10-08

5.  Awareness of diabetic foot disease amongst patients with type 2 diabetes mellitus attending the chronic outpatients department at a regional hospital in Durban, South Africa.

Authors:  Thea T Goie; Mergan Naidoo
Journal:  Afr J Prim Health Care Fam Med       Date:  2016-11-17

6.  Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing.

Authors:  Eunhui Seo; Jae Soo Lim; Jin-Bum Jun; Woohyuk Choi; In-Sun Hong; Hee-Sook Jun
Journal:  J Transl Med       Date:  2017-02-15       Impact factor: 5.531

7.  8th Asian PAD Workshop.

Authors: 
Journal:  Ann Vasc Dis       Date:  2017-12-25

8.  Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway.

Authors:  Wei Liu; Muyu Yu; Dong Xie; Longqing Wang; Cheng Ye; Qi Zhu; Fang Liu; Lili Yang
Journal:  Stem Cell Res Ther       Date:  2020-06-29       Impact factor: 6.832

9.  In situ eNOS/NO up-regulation-a simple and effective therapeutic strategy for diabetic skin ulcer.

Authors:  Ye Yang; Dengke Yin; Fei Wang; Ziyan Hou; Zhaohui Fang
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

Review 10.  Diabetic Foot Ulcers and Epidermal Growth Factor: Revisiting the Local Delivery Route for a Successful Outcome.

Authors:  Jorge Berlanga-Acosta; José Fernández-Montequín; Calixto Valdés-Pérez; William Savigne-Gutiérrez; Yssel Mendoza-Marí; Ariana García-Ojalvo; Viviana Falcón-Cama; Diana García Del Barco-Herrera; Maday Fernández-Mayola; Héctor Pérez-Saad; Eulogio Pimentel-Vázquez; Aleida Urquiza-Rodríguez; Moshe Kulikovsky; Gerardo Guillén-Nieto
Journal:  Biomed Res Int       Date:  2017-08-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.